NIH R01 · 2025
ABSTRACT Individuals living with likely incurable cancer (ILLIC) are a heterogeneous, growing subpopulation of cancer survivors who have unique survivorship care needs. Principal among these is the need for psychosocial treatment. Treatment of depression is particularly critical as up to half of ILLIC report depressive symptoms, with negative sequalae including lower quality of life, desire for hastened death, and suicidality. Numerous trials and meta-analyses have documented that evidence-based psychosocial treatment improves depression outcomes for ILLIC. However, multilevel barriers limit access. Thus, ILLIC need feasible, accessible depression treatment options. Brief depression…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.